Other
Bone Health
0
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Bone Health is an early-stage landscape with 0 programs across 1 company. The most active players are Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Completed6 · 67%
Recruiting1 · 11%
Unknown status1 · 11%
Withdrawn1 · 11%
Clinical Trials
Trial Activity
9 trials
Rhythmic Estradiol and Bone Health
Completed·—·Phase 4·NCT05903820·48 enrolled
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
Completed·AAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections·Phase 2·NCT01403051·167 enrolled
Effect of Reducing Nucleotide Exposure on Bone Health (ReNew)
Withdrawn·—·Phase 2·NCT03549689
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)